ArticleFrontiers in immunology2023

A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors.

Shawn Iadonato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.